P131 Phase I trial of the combination of the epigenetic modulators vorinostat and azacitidine (azaC) in patients with the myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). An update from the NY Cancer Consortium

Leukemia Research

Volumn 33, Issue SUPPL. 1, 2009, Pages

  Silverman, L ^a   Verma, A ^a   Odchimar Reissig, R ^a   LeBlane, A ^a   Najfeld, V ^a   Gabrilove, J ^a   Isola, L ^a   Espinoza Delgado, I ^a   Zwiebel, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65349086724     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(09)70212-7     Document Type: Article

References (0)